This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tratschin, J D Articles by Carter, B J Search for Related Content PubMed PubMed Citation Articles by Tratschin, J D Articles by Carter, B J

 Previous Article  |  Next Article 

Mol Cell Biol. 1984 October; 4(10): 2072-2081

A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase.

ABSTRACT

We have used the defective human parvovirus adeno-associated virus (AAV) as a novel eucaryotic vector (parvector) for the expression of a foreign gene in human cells. The recombinant, pAV2, contains the AAV genome in a pBR322-derived bacterial plasmid. When pAV2 is transfected into human cells together with helper adenovirus particles, the AAV genome is rescued from the recombinant plasmid and replicated to produce infectious AAV particles at high efficiency. To create a vector, we inserted a procaryotic sequence coding for chloramphenicol acetyltransferase (CAT) into derivatives of pAV2 following either of the AAV promoters p40 (pAVHiCAT) and p19 (pAVBcCAT). When transfected into human 293 cells or HeLa cells, pAVHiCAT expressed CAT activity in the absence of adenovirus. In the presence of adenovirus, this vector produced increased amounts of CAT activity and the recombinant AAV-CAT genome was replicated. In 293 cells, pAVBcCAT expressed a similar amount of CAT activity in the absence or presence of adenovirus and the recombinant AAV-CAT genome was not replicated. In HeLa cells, pAVBcCAT expressed low levels of CAT activity, but this level was elevated by coinfection with adenovirus particles or by cotransfection with a plasmid which expressed the adenovirus early region 1A (E1A) product. The E1A product is a transcriptional activator and is expressed in 293 cells. Thus, expression from two AAV promoters is differentially regulated: expression from p19 is increased by E1A, whereas p40 yields high levels of constitutive expression in the absence of E1A. Both AAV vectors were packaged into AAV particles by complementation with wild-type AAV and yielded CAT activity when subsequently infected into cells in the presence of adenovirus.

This article has been cited by other articles:

• Nienhuis, A. W. (2008). Development of gene therapy for blood disorders. Blood 111: 4431-4444 [Abstract] [Full Text]  
• Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., Auricchio, A. (2007). Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors. J. Virol. 81: 11372-11380 [Abstract] [Full Text]  
• Hermonat, P. L., Li, D., Yang, B., Mehta, J. L. (2007). Mechanism of action and delivery possibilities for TGF{beta}1 in the treatment of myocardial ischemia. Cardiovasc Res 74: 235-243 [Abstract] [Full Text]  
• Matsushita, T., Okada, T., Inaba, T., Mizukami, H., Ozawa, K., Colosi, P. (2004). The adenovirus E1A and E1B19K genes provide a helper function for transfection-based adeno-associated virus vector production. J. Gen. Virol. 85: 2209-2214 [Abstract] [Full Text]  
• Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., Siegal, G. P. (2001). Adeno-associated Virus for Cancer Gene Therapy. Cancer Res. 61: 6313-6321 [Full Text]  
• Moser, C., Tratschin, J.-D., Hofmann, M. A. (1998). A Recombinant Classical Swine Fever Virus Stably Expresses a Marker Gene. J. Virol. 72: 5318-5322 [Abstract] [Full Text]